the evaluation of the appropriate dose of dexmedetomidine under Sedline which is the new monitoring for the degree of sedation

the evaluation of the appropriate dose of dexmedetomidine under Sedline which is the new monitoring for the degree of sedation - the evaluation of the appropriate dose of dexmedetomidine under Sedline which is the new monitoring for the degree of sedation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021688

Enrollment

Registered

2016-03-31

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the patients proposed operation under local anesthesia

Interventions

low dose of dexmedetomidine group: 6 microgram/kg /hr dexmedetomidine was administered over a period of 10 minutes as a loading dose, and then maintenance infusion (0.2 microgram/kg/hr) was started. m

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients which has ASA PS I or II and proposed operation under local anesthesia

Exclusion criteria

Exclusion criteria: the patients who has difficulty in mutual understanding , has difficulty to get cooperation, has cardiovascular or respiratory or neurological complication

Design outcomes

Primary

Measure	Time frame
the change of the degree of sedation, respiratory rate, oxygenation, systolic blood pressure and heart rate at every 15 minutes, and RASS score at the operation finished	—

Countries

Japan

Contacts

Public ContactKouji Hamaya

Sapporo Medical University School of Medicine Hospital section

ko-hamaya-923@sapmed.ac.jp011-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026